Fractyl Health, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
S-1/A: Fractyl Health Eyes Nasdaq Debut with $110 Million IPO to Advance Metabolic Disease Therapies
Fractyl Health, a metabolic therapeutics company, is seeking to raise $110 million through an initial public offering to fund the development of its Revita and Rejuva therapies targeting type 2 diabetes and obesity.